Novo Nordisk and Eli Lilly shares slide on new obesity drug trial from Roche

4 months ago

Novo Nordisk and Eli Lilly shares slid Wednesday on promising early-stage trial data from Roche’s latest obesity drug candidate. 

More Stories

The difficulty of working as a medic in Gaza

58 mins ago

Lebanese PM calls on Israel to commit to truce and withdraw

58 mins ago

ICC prosecutor seeks arrest warrant for Myanmar military regime chief

58 mins ago

Leave a Reply

Your email address will not be published. Required fields are marked *

You may have missed

EFCC arraigns ex-Kogi governor Yahaya Bello on N110bn fraud charges

58 mins ago

Yahaya Bello controls courtroom crowd as judge angrily halts hearing over disorder

58 mins ago

At AFREXIM Investment Conference, Kenya, Gov Lawal says Zamfara open for partnerships

58 mins ago

Anatomy of an epic Man City collapse

58 mins ago

The difficulty of working as a medic in Gaza

58 mins ago